Free Trial

Orthofix Medical (OFIX) Competitors

Orthofix Medical logo
$18.65 -0.06 (-0.32%)
Closing price 01/30/2025 04:00 PM Eastern
Extended Trading
$18.43 -0.22 (-1.18%)
As of 07:21 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OFIX vs. IART, ATRC, ATEC, SRDX, ANGO, ARAY, RMTI, RSLS, ABT, and ISRG

Should you be buying Orthofix Medical stock or one of its competitors? The main competitors of Orthofix Medical include Integra LifeSciences (IART), AtriCure (ATRC), Alphatec (ATEC), Surmodics (SRDX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "health care equipment" industry.

Orthofix Medical vs.

Orthofix Medical (NASDAQ:OFIX) and Integra LifeSciences (NASDAQ:IART) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment, analyst recommendations and community ranking.

89.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 2.6% of Orthofix Medical shares are held by company insiders. Comparatively, 3.1% of Integra LifeSciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Integra LifeSciences has a net margin of -0.42% compared to Orthofix Medical's net margin of -15.18%. Integra LifeSciences' return on equity of 12.35% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Orthofix Medical-15.18% -21.25% -13.29%
Integra LifeSciences -0.42%12.35%4.82%

Integra LifeSciences received 22 more outperform votes than Orthofix Medical when rated by MarketBeat users. However, 62.03% of users gave Orthofix Medical an outperform vote while only 56.83% of users gave Integra LifeSciences an outperform vote.

CompanyUnderperformOutperform
Orthofix MedicalOutperform Votes
415
62.03%
Underperform Votes
254
37.97%
Integra LifeSciencesOutperform Votes
437
56.83%
Underperform Votes
332
43.17%

In the previous week, Orthofix Medical had 4 more articles in the media than Integra LifeSciences. MarketBeat recorded 9 mentions for Orthofix Medical and 5 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.26 beat Orthofix Medical's score of 0.92 indicating that Integra LifeSciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Orthofix Medical
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Integra LifeSciences
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Integra LifeSciences has higher revenue and earnings than Orthofix Medical. Integra LifeSciences is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orthofix Medical$746.64M0.95-$151.40M-$3.13-5.96
Integra LifeSciences$1.56B1.30$67.74M-$0.09-292.67

Orthofix Medical currently has a consensus target price of $23.33, suggesting a potential upside of 25.11%. Integra LifeSciences has a consensus target price of $23.00, suggesting a potential downside of 12.68%. Given Orthofix Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Orthofix Medical is more favorable than Integra LifeSciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix Medical
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Integra LifeSciences
3 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.75

Orthofix Medical has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500.

Summary

Integra LifeSciences beats Orthofix Medical on 11 of the 17 factors compared between the two stocks.

Get Orthofix Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OFIX vs. The Competition

MetricOrthofix MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$714.99M$4.89B$5.58B$9.14B
Dividend YieldN/A51.40%5.31%3.98%
P/E RatioN/A13.9659.3713.99
Price / Sales0.9556.021,195.0781.21
Price / CashN/A52.0545.8137.80
Price / Book1.168.245.174.72
Net Income-$151.40M$89.76M$106.41M$224.20M
7 Day Performance1.63%-1.64%0.79%0.50%
1 Month Performance6.82%9.03%3.84%2.13%
1 Year Performance34.27%30.46%26.25%21.21%

Orthofix Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OFIX
Orthofix Medical
3.7272 of 5 stars
$18.65
-0.3%
$23.33
+25.1%
+31.9%$714.99M$746.64M0.001,634Analyst Upgrade
Short Interest ↓
News Coverage
IART
Integra LifeSciences
3.2613 of 5 stars
$26.37
+1.2%
$23.00
-12.8%
-35.6%$2.03B$1.54B-292.973,720Short Interest ↓
Positive News
ATRC
AtriCure
1.5499 of 5 stars
$40.84
+0.6%
$43.38
+6.2%
+19.7%$1.99B$399.24M-49.201,200
ATEC
Alphatec
4.3048 of 5 stars
$11.13
+1.1%
$17.56
+57.7%
-28.1%$1.58B$482.26M-8.70700
SRDX
Surmodics
4.3688 of 5 stars
$37.99
-0.4%
$50.00
+31.6%
+1.5%$542.88M$126.08M-46.90450Earnings Report
Upcoming Earnings
Analyst Forecast
Short Interest ↑
Analyst Revision
News Coverage
ANGO
AngioDynamics
4.0262 of 5 stars
$12.21
+0.2%
$13.00
+6.5%
+108.7%$494.22M$303.91M-2.17760Short Interest ↓
ARAY
Accuray
4.4714 of 5 stars
$2.22
-2.6%
$9.00
+305.4%
-14.1%$223.27M$446.55M-13.061,040Upcoming Earnings
Short Interest ↑
RMTI
Rockwell Medical
4.3783 of 5 stars
$2.06
-6.4%
$6.00
+191.3%
+45.8%$66.58M$83.61M-41.20300Gap Down
RSLS
ReShape Lifesciences
1.1294 of 5 stars
$4.36
-1.9%
N/A-69.5%$3.18M$8.68M0.0050Short Interest ↓
ABT
Abbott Laboratories
4.9033 of 5 stars
$129.51
+3.6%
$133.06
+2.7%
+13.5%$224.63B$41.95B16.93114,000Analyst Upgrade
Short Interest ↑
ISRG
Intuitive Surgical
4.7016 of 5 stars
$573.48
-1.8%
$613.10
+6.9%
+53.8%$204.26B$7.12B92.2013,676Insider Trade
Short Interest ↑

Related Companies and Tools


This page (NASDAQ:OFIX) was last updated on 1/31/2025 by MarketBeat.com Staff
From Our Partners